FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology and concerns using comenic acid sodium salt as a preventive and therapeutic antioxidant, stress and neuroprotective agent in the amount of 1 to 4 mg per 1 kg of body weight daily on the empty stomach for 3 days.
EFFECT: invention provides the high clinical effectiveness.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE PHARMACOLOGICAL AGENT POTASSIUM COMENATE | 2012 |
|
RU2514632C1 |
| METHOD FOR PREPARING LITHIUM SALT OF COMENIC ACID AND USING IT AS ANTIOXIDANT, STRESS- AND NEUROPROTECTIVE AGENT | 2011 |
|
RU2477722C1 |
| PHARMACOLOGICAL NEUROPROTECTIVE DRUG | 2014 |
|
RU2561045C1 |
| NEUROPROTECTIVE PHARMACEUTICAL AGENT | 2013 |
|
RU2528914C1 |
| METHOD OF PREVENTING AND CORRECTION OF DISTURBANCES OF MAIN FUNCTIONS OF CENTRAL NERVOUS SYSTEM IN CASE OF LEAD INTOXICATION IN PRENATAL AND EARLY POSTPARTUM PERIOD | 2009 |
|
RU2410107C1 |
| NEUROPROTECTIVE AGENT | 2016 |
|
RU2614697C1 |
| METHOD FOR PREVENTING AND CORRECTING METABOLIC AND FUNCTIONAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM UNDER STRESS CONDITIONS | 2019 |
|
RU2717107C1 |
| COMBINED DRUG FOR PRIMARY NEUROPROTECTION | 2017 |
|
RU2636616C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS OF CARDIOVASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOIMMUNE GENESIS | 2010 |
|
RU2445106C1 |
| METHOD FOR PREVENTING AND TREATING NEURODEGENERATIVE PATHOLOGY AND VASCULAR DEMENTIA | 2014 |
|
RU2587617C1 |
